These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27647218)

  • 21. GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.
    Sapkota K; Mao Z; Synowicki P; Lieber D; Liu M; Ikezu T; Gautam V; Monaghan DT
    J Pharmacol Exp Ther; 2016 Mar; 356(3):702-11. PubMed ID: 26675679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.
    Umbricht D; Vollenweider FX; Schmid L; Grübel C; Skrabo A; Huber T; Koller R
    Neuropsychopharmacology; 2003 Jan; 28(1):170-81. PubMed ID: 12496954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficits in Cortical Suppression During Vocalization are Associated With Structural Abnormalities in the Arcuate Fasciculus in Early Illness Schizophrenia and Clinical High Risk for Psychosis.
    Whitford TJ; Oestreich LKL; Ford JM; Roach BJ; Loewy RL; Stuart BK; Mathalon DH
    Schizophr Bull; 2018 Oct; 44(6):1312-1322. PubMed ID: 29194516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensory transduction of weak electromagnetic fields: role of glutamate neurotransmission mediated by NMDA receptors.
    Frilot C; Carrubba S; Marino AA
    Neuroscience; 2014 Jan; 258():184-91. PubMed ID: 24239718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242.
    Ranganathan M; DeMartinis N; Huguenel B; Gaudreault F; Bednar MM; Shaffer CL; Gupta S; Cahill J; Sherif MA; Mancuso J; Zumpano L; D'Souza DC
    Mol Psychiatry; 2017 Nov; 22(11):1633-1640. PubMed ID: 28242871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine.
    Kantrowitz JT; Epstein ML; Beggel O; Rohrig S; Lehrfeld JM; Revheim N; Lehrfeld NP; Reep J; Parker E; Silipo G; Ahissar M; Javitt DC
    Brain; 2016 Dec; 139(Pt 12):3281-3295. PubMed ID: 27913408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-methyl-D-aspartate receptor hypofunction in schizophrenia could arise from reduced cortical connectivity rather than receptor dysfunction.
    Hoffman RE; McGlashan TH
    Arch Gen Psychiatry; 1997 Jun; 54(6):578-80. PubMed ID: 9193200
    [No Abstract]   [Full Text] [Related]  

  • 29. N-methyl-D-aspartate receptor in working memory impairments in schizophrenia: event-related potential study of late stage of working memory process.
    Ahn KH; Youn T; Cho SS; Ha TH; Ha KS; Kim MS; Kwon JS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):993-9. PubMed ID: 14499316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
    Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
    Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired cortical network for preattentive detection of change in speech sounds in schizophrenia: a high-resolution event-related potential study.
    Kasai K; Nakagome K; Itoh K; Koshida I; Hata A; Iwanami A; Fukuda M; Kato N
    Am J Psychiatry; 2002 Apr; 159(4):546-53. PubMed ID: 11925291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia.
    Jadi MP; Behrens MM; Sejnowski TJ
    Biol Psychiatry; 2016 May; 79(9):716-726. PubMed ID: 26281716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.
    Roser P; Haussleiter IS; Chong HJ; Maier C; Kawohl W; Norra C; Juckel G
    Psychopharmacology (Berl); 2011 Dec; 218(4):611-20. PubMed ID: 21590281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamatergic modulation of auditory information processing in the human brain.
    Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
    Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.
    Thiebes S; Leicht G; Curic S; Steinmann S; Polomac N; Andreou C; Eichler I; Eichler L; Zöllner C; Gallinat J; Hanganu-Opatz I; Mulert C
    J Psychiatry Neurosci; 2017 Jun; 42(4):273-283. PubMed ID: 28556775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in interhemispheric gamma-band connectivity are related to the emergence of auditory verbal hallucinations in healthy subjects during NMDA-receptor blockade.
    Thiebes S; Steinmann S; Curic S; Polomac N; Andreou C; Eichler IC; Eichler L; Zöllner C; Gallinat J; Leicht G; Mulert C
    Neuropsychopharmacology; 2018 Jun; 43(7):1608-1615. PubMed ID: 29453445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis.
    Daumann J; Wagner D; Heekeren K; Neukirch A; Thiel CM; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2010 Oct; 24(10):1515-24. PubMed ID: 19304859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia.
    Adler CM; Malhotra AK; Elman I; Goldberg T; Egan M; Pickar D; Breier A
    Am J Psychiatry; 1999 Oct; 156(10):1646-9. PubMed ID: 10518181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-methyl-d-aspartate receptor antagonist ketamine impairs action-monitoring activity in the prefrontal cortex.
    Skoblenick K; Everling S
    J Cogn Neurosci; 2014 Mar; 26(3):577-92. PubMed ID: 24188365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.
    Schmidt A; Bachmann R; Kometer M; Csomor PA; Stephan KE; Seifritz E; Vollenweider FX
    Neuropsychopharmacology; 2012 Mar; 37(4):865-75. PubMed ID: 22030715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.